Capricor Therapeutics
CAPR
#7980
Rank
HK$2.26 B
Marketcap
HK$49.49
Share price
-4.36%
Change (1 day)
-57.79%
Change (1 year)

Capricor Therapeutics (CAPR) - Cash on Hand

Cash on Hand as of September 2025 : HK$0.76 Billion

According to Capricor Therapeutics 's latest financial reports the company has HK$0.76 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Capricor Therapeutics - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$1.17 B281.42%
2023-12-31HK$0.30 B-4.71%
2022-12-31HK$0.32 B18.97%
2021-12-31HK$0.27 B7.42%
2020-12-31HK$0.25 B228.92%
2019-12-31HK$76.98 M35.48%
2018-12-31HK$56.82 M-48.51%
2017-12-31HK$0.11 B-12.12%
2016-12-31HK$0.12 B19.43%
2015-12-31HK$0.10 B68.73%
2014-12-31HK$62.32 M290.9%
2013-12-31HK$15.94 M-52.85%
2012-12-31HK$33.81 M318.98%
2011-12-31HK$8.07 M-69.3%
2010-12-31HK$26.28 M6.77%
2009-12-31HK$24.62 M-42.07%
2008-12-31HK$42.5 M-66.42%
2007-12-31HK$0.12 B
2005-12-31HK$0 M-55.85%
2004-12-31HK$0 M-41%
2003-12-31HK$0 M4189.82%
2002-12-31HK$0 M-83.97%
2001-12-31HK$0 M-98.82%
2000-12-31HK$0.1 M
1999-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Cytokinetics
CYTK
HK$7.48 B 876.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$19.6 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$144.43 B 18,732.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$8.67 B 1,031.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$4.53 B 491.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$23.7 M-96.91%๐Ÿ‡บ๐Ÿ‡ธ USA